Market Movers : Hertz Global (NYSE:HTZ), IAMGOLD (NYSE:IAG), Repros Therapeutics Inc. (NASDAQ:RPRX), Rocket Fuel Inc. (NASDAQ:FUEL), Genomic Health Inc. (NASDAQ:GHDX),

Hertz Global Holdings (NYSE:HTZ) was downgraded by Zacks from a “neutral” rating to an “underperform” rating in a research note issued on Tuesday. They currently have a $26.10 target price on the stock. Zacks‘s target price suggests a potential downside of 5.43% from the stock’s previous close. Hertz Global Holdings, Inc. (NYSE:HTZ) belongs to Services sector. Its net profit margin is 6.50% and weekly performance is -0.69%. On last trading day company shares ended up $27.51. Hertz Global Holdings, Inc. (NYSE:HTZ) distance from 50-day simple moving average (SMA50) is -4.46%.

IAMGOLD Corp. (NYSE: IAG) provided an update from its ongoing exploration program at its newly optioned Monster Lake project located 50 kilometres southwest of Chibougamau, Quebec, Canada. IAMGOLD Corp. (NYSE:IAG) shares fell -2.65% in last trading session and ended the day at $3.30. IAG Gross Margin is 20.30% and its return on assets is -18.60%. IAMGOLD Corp. (NYSE:IAG) quarterly performance is -18.52%.

Repros Therapeutics Inc. (NASDAQ:RPRX) is up almost 20% during trading, on news of successful trial results for its low testosterone treating drug. The trial of the drug was being conducted against a leading treatment of low testosterone and a placebo with two primary end-points. Repros’s drug Androxal showed better results in both measures of the trial and also had statistically significant results for the secondary endpoints. On 17 September, Repros Therapeutics Inc. (NASDAQ:RPRX) shares fell -10.49% and was closed at $12.88. RPRX EPS growth in last 5 year was 29.30%. Repros Therapeutics Inc. (NASDAQ:RPRX) year to date (YTD) performance is -29.62%.

Rocket Fuel (NASDAQ:FUEL) had its price target upped by Evercore Partners from $15.00 to $17.00 in a research note issued to investors on Friday. The firm currently has an equal weight rating on the stock. Rocket Fuel Inc. (NASDAQ:FUEL) ended the last trading day at $15.45. Company weekly volatility is calculated as 11.15% and price to cash ratio as 2.72. Rocket Fuel Inc. (NASDAQ:FUEL) showed a weekly performance of 6.19%.

Leading genomic-based clinical laboratory services provider Genomic Health Inc. (NASDAQ:GHDX) recently reported positive outcome of a health economic analysis that were also published in peer-reviewed medical journal PharmacoEconomics. Genomic Health Inc. (NASDAQ:GHDX) shares increased 0.97% in last trading session and ended the day at $29.22. GHDX Gross Margin is 83.10% and its return on assets is -11.90%. Genomic Health Inc. (NASDAQ:GHDX) quarterly performance is 4.39%.

Signup for free to be the first to receive exclusive free links. Now in your mailbox!
Join over 15,000 subscribers
Send me links

Your information will not be shared to anyone